tm
Seeing Is Believing
tm
Seeing Is Believing
TRDA is currently covered by 2 analysts with an average price target of $15.92. This is a potential upside of $3.2 (25.16%) from yesterday's end of day stock price of $12.72.
Entrada Therapeutics's activity chart (see below) currently has 1 price targets and 10 ratings on display. The stock rating distribution of TRDA is 22.22% HOLD and 77.78% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 3.5 days.
Highest price target for TRDA is $20, Lowest price target is $20, average price target is $15.92.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Mar-2024. First documented stock forecast 23-Nov-2021.
Currently out of the existing stock ratings of TRDA, 2 are a HOLD (22.22%), 7 are a BUY (77.78%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
20
$6.55 (48.70%)
20
1 months ago
0/7 (0%)
$7.59 (61.16%)
Hold
18
$4.55 (33.83%)
13
1 years 5 months 10 days ago
3/3 (100%)
$-1.2 (-6.25%)
7
What is TRDA (Entrada Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TRDA (Entrada Therapeutics) with a proven track record?
Which analyst has the current lower performing score on TRDA (Entrada Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TRDA (Entrada Therapeutics)?
Which analyst is the currently most bullish on TRDA (Entrada Therapeutics)?
Which analyst is the currently most reserved on TRDA (Entrada Therapeutics)?
